Plain-English translation of NCT06373419 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different laser technologies—the Thulium Fiber Laser (TFL) and the MOSES Holmium laser—to see which one works better for removing bladder tumors. Both lasers remove the tumor in one complete piece rather than breaking it into fragments. The goal is to find which approach gives doctors better information about your tumor and causes fewer complications.
Current bladder tumor removal procedures have a high rate of cancer returning and can cause complications like bleeding or bladder injury. Additionally, breaking the tumor into pieces during removal makes it harder for doctors to analyze the tissue under a microscope. This trial exists to determine if one of these laser techniques offers safer, more effective tumor removal with better outcomes for patients.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to receive bladder tumor removal using either the Thulium Fiber Laser or the MOSES Holmium laser. The procedure itself (called transurethral resection) is performed by a urologist and removes your tumor through the urethra without requiring an external incision. After surgery, your removed tumor tissue will be examined under a microscope to guide any further treatment you may need.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Canada